Tobacco smoking after diagnosis of cancer: clinical aspects.
作者： Jacek Jassem
关键词: Lung cancer 、 Health care 、 Disease 、 Medicine 、 Tobacco use 、 Intensive care medicine 、 Cancer 、 Clinical trial 、 Smoking cessation 、 Quality of life
摘要: Tobacco smoking accounts for at least 30% of all cancer deaths and nearly 90% lung deaths. Smoking cessation significantly reduces the risk developing tobacco-related malignancies. after diagnosis is also associated with multiple risks, including worse tolerance treatment, higher a failure second primary tumors, poorer quality life. Apart from disease site stage, continued considered strongest adverse predictor survival in patients. However, benefits are undervalued: many patients not aware harms related to tobacco use diagnosis. Furthermore, health care professionals often do encourage their quit, provide assistance continuing users. Despite apparent impact on treatment outcomes, data current status only rarely captured clinical trials This article reviews most important aspects cancer.
amegroups.com参考文章(108)
Ann M Møller, Nete Villebro, Tom Pedersen, Hanne Tønnesen, Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial The Lancet. ,vol. 359, pp. 114- 117 ,(2002) , 10.1016/S0140-6736(02)07369-5
M. J. Hooning, A. Botma, B. M. P. Aleman, M. H. A. Baaijens, H. Bartelink, J. G. M. Klijn, C. W. Taylor, F. E. van Leeuwen, Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. Journal of the National Cancer Institute. ,vol. 99, pp. 365- 375 ,(2007) , 10.1093/JNCI/DJK064
Ellen R. Gritz, Chris Schacherer, Laura Koehly, Ingrid R. Nielsen, Elliot Abemayor, Smoking withdrawal and relapse in head and neck cancer patients. Head and Neck-journal for The Sciences and Specialties of The Head and Neck. ,vol. 21, pp. 420- 427 ,(1999) , 10.1002/(SICI)1097-0347(199908)21:5<420::AID-HED7>3.0.CO;2-U
M. Kanai, S. Morita, S. Matsumoto, T. Nishimura, E. Hatano, S. Yazumi, T. Sasaki, H. Yasuda, T. Kitano, A. Misawa, H. Ishiguro, K. Yanagihara, I. Ikai, R. Doi, M. Fukushima, A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia Annals of Oncology. ,vol. 20, pp. 1397- 1401 ,(2009) , 10.1093/ANNONC/MDP008
Marta Hamilton, Julie L. Wolf, Jason Rusk, Shannon E. Beard, Gary M. Clark, Karsten Witt, Pablo J. Cagnoni, Effects of Smoking on the Pharmacokinetics of Erlotinib Clinical Cancer Research. ,vol. 12, pp. 2166- 2171 ,(2006) , 10.1158/1078-0432.CCR-05-2235
Johannes C.M van der Voet, Ronald B Keus, Augustinus A.M Hart, Frans J.M Hilgers, Harry Bartelink, The impact of treatment time and smoking on local control and complications in T1 glottic cancer International Journal of Radiation Oncology Biology Physics. ,vol. 42, pp. 247- 255 ,(1998) , 10.1016/S0360-3016(98)00226-0
Anne-Joy M. de Graan, Walter J. Loos, Lena E. Friberg, Sharyn D. Baker, Jessica M. van der Bol, Leni van Doorn, Erik A.C. Wiemer, Bronno van der Holt, Jaap Verweij, Ron H.J. Mathijssen, Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy Clinical Cancer Research. ,vol. 18, pp. 4425- 4432 ,(2012) , 10.1158/1078-0432.CCR-12-0728
T. Thomsen, H. Tønnesen, A. M. Møller, Effect of preoperative smoking cessation interventions on postoperative complications and smoking cessation British Journal of Surgery. ,vol. 96, pp. 451- 461 ,(2009) , 10.1002/BJS.6591
Fadlo R. Khuri, Fadlo R. Khuri, Steven E. Benner, Helmuth Goepfert, Helmuth Goepfert, Brendell Williams, Edward S. Kim, Jay S. Cooper, Robert M. Chamberlain, Waun K. Hong, Waun K. Hong, Rodger J. Winn, Thomas F. Pajak, Scott M. Lippman, J. Jack Lee, Everett E. Vokes, Karen K. Fu, The Impact of Smoking Status, Disease Stage, and Index Tumor Site on Second Primary Tumor Incidence and Tumor Recurrence in the Head and Neck Retinoid Chemoprevention Trial Cancer Epidemiology, Biomarkers & Prevention. ,vol. 10, pp. 823- 829 ,(2001)
Ellen R. Gritz, Cindy L. Carmack, Carl de Moor, Anne Coscarelli, Christopher W. Schacherer, Eric G. Meyers, Elliot Abemayor, First year after head and neck cancer: quality of life. Journal of Clinical Oncology. ,vol. 17, pp. 352- 360 ,(1999) , 10.1200/JCO.1999.17.1.352